Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Conducting Long-Term Stability Studies on Emulsions

Posted on By

SOP for Conducting Long-Term Stability Studies on Emulsions

Conducting Long-Term Stability Studies on Emulsions

1) Purpose

The purpose of this SOP is to outline the procedure for conducting long-term stability studies on emulsion formulations. These studies assess the physical, chemical, and microbiological stability of emulsions over time, ensuring their quality and efficacy throughout the product’s shelf life.

2) Scope

This SOP applies to personnel involved in formulation, quality control, and stability testing of emulsions. It covers the preparation, storage, and testing of emulsions under different storage conditions for long-term stability.

3) Responsibilities

  • Formulation Scientists: Responsible for preparing emulsion batches for stability testing and ensuring proper documentation of all data.
  • QC Team: Responsible for conducting stability tests, such as droplet size analysis, zeta potential, and chemical stability tests at regular intervals.
  • QA Team: Responsible for reviewing the stability study results and ensuring compliance with regulatory standards.

4) Procedure

4.1 Sample Preparation

  • 4.1.1 Prepare emulsion formulations as per the approved manufacturing procedure, ensuring that samples are representative of the production batch.
  • 4.1.2 Label each sample with the batch number, preparation date, and storage conditions.
  • 4.1.3 Store the samples under various conditions (e.g., 25°C/60% RH, 30°C/65% RH, 40°C/75% RH) as per the stability protocol.
See also  SOP for Preparation of Double Emulsions (W/O/W or O/W/O)

4.2 Parameters for Stability Testing

The following parameters should be monitored at regular intervals during

the long-term stability study:

  • 4.2.1 Droplet Size Distribution: Measure droplet size using dynamic light scattering (DLS) or laser diffraction to assess any changes in size over time.
  • 4.2.2 Zeta Potential: Measure the zeta potential of the emulsion to assess its colloidal stability. A higher absolute zeta potential typically indicates better stability.
  • 4.2.3 Viscosity: Measure the viscosity of the emulsion at regular intervals. Changes in viscosity may indicate phase separation or instability.
  • 4.2.4 pH: Measure the pH at each testing interval, as significant changes may indicate chemical instability or ingredient degradation.
  • 4.2.5 Visual Inspection: Perform a visual inspection to check for signs of creaming, phase separation, or sedimentation.
See also  SOP for Preparation of Liposomes for Gene Delivery

4.3 Testing Schedule

  • 4.3.1 Initial Test: Conduct initial stability tests immediately after preparing the emulsion to establish baseline values.
  • 4.3.2 Interim Tests: Perform tests at specified intervals (e.g., 1 month, 3 months, 6 months) depending on the storage conditions.
  • 4.3.3 Final Test: Conduct the final stability test at the end of the study period (e.g., 12 months or 24 months).

4.4 Data Recording and Analysis

  • 4.4.1 Record all test results in the Stability Study Report (see Annexure 1).
  • 4.4.2 Analyze test results over time to identify trends in droplet size, zeta potential, and viscosity.
  • 4.4.3 Compare data from different storage conditions to determine the optimal environment for long-term stability of the emulsion.

4.5 Acceptance Criteria

The emulsion formulation is considered stable if the following criteria are met throughout the study period:

  • 4.5.1 Droplet size remains within acceptable limits, with no significant coalescence or growth.
  • 4.5.2 Zeta potential remains stable, indicating good colloidal stability.
  • 4.5.3 Viscosity remains consistent, with no signs of phase separation or instability.
  • 4.5.4 pH remains stable, with no significant changes indicating chemical instability.
See also  SOP for Evaluation of Emulsion Droplet Size Changes Over Time

5) Abbreviations

  • DLS: Dynamic Light Scattering
  • QC: Quality Control
  • QA: Quality Assurance

6) Documents

  • Batch Manufacturing Record (BMR)
  • Stability Study Report
  • Droplet Size Analysis Report
  • Zeta Potential Measurement Report
  • Viscosity Measurement Report

7) References

  • ICH Q1A: Stability Testing of New Drug Substances and Products
  • FDA Guidelines for Stability Testing of Emulsion Drug Products

8) SOP Version

Version 1.0

Annexure

Annexure 1: Stability Study Report Template

Time Point Storage Condition Droplet Size (nm) Zeta Potential (mV) Viscosity (cP) pH Visual Inspection Operator Initials
Initial 25°C/60% RH 100-300 nm -30 to -50 mV 10 cP 7.0 No creaming Operator Name
3 Months 30°C/65% RH 100-300 nm -30 to -50 mV 10 cP 7.0 No creaming Operator Name
Liposome and Emulsion Formulations Tags:Antioxidants in emulsions, API incorporation in emulsions, API incorporation in liposomes, Chemical stability testing liposomes, Cosmetic emulsion formulation, Emulsion droplet size analysis, Emulsion formulation SOP, Emulsion microbiological stability, Emulsion stability testing, Freeze-thaw stability testing, Heat-sensitive liposomes, High-shear mixing emulsions, Liposomal drug delivery SOP, Liposomal vaccines SOP, Liposome formulation SOP, Liposome particle size analysis, Liposome preparation procedure, Liposome size distribution, Liposome stability testing, Nanoemulsion SOP, Parenteral emulsion preparation, pH-responsive emulsions, Physical stability liposomes, Self-emulsifying drug delivery systems (SEDDS), Thin-film hydration liposomes

Post navigation

Previous Post: SOP for Employee Training and Competency Development
Next Post: SOP for Waste Management and Disposal in GMP Facilities

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version